These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1607777)

  • 1. [Changes in various differentiation-related makers after differentiation induction of a pluripotent human embryonal carcinoma (EC) cell line by hexamethylene bisacetamide (HMBA)].
    Tanaka T
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Apr; 44(4):513. PubMed ID: 1607777
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in various differentiation-related markers after differentiation induction of a pluripotent human embryonal carcinoma (EC) cell line by hexamethylene bisacetamide].
    Kimura H; Sekiya S; Kawata M; Takamizawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Nov; 43(11):1477-83. PubMed ID: 1682397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fundamental studies on differentiation inducers using a human embryonal carcinoma model].
    Yamazawa K; Sekiya S; Kimura H; Shirasawa H; Kawata M; Takamizawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Oct; 43(10):1303-9. PubMed ID: 1955781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Wnt-13 is developmentally regulated during the differentiation of NTERA-2 pluripotent human embryonal carcinoma cells.
    Wakeman JA; Walsh J; Andrews PW
    Oncogene; 1998 Jul; 17(2):179-86. PubMed ID: 9674702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by osteogenic protein-1 (or bone morphogenetic protein-7).
    Andrews PW; Damjanov I; Berends J; Kumpf S; Zappavigna V; Mavilio F; Sampath K
    Lab Invest; 1994 Aug; 71(2):243-51. PubMed ID: 7521445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of differentiation of human promyelocytic leukemia cells (HL60) by metabolites of hexamethylene bisacetamide.
    Snyder SW; Egorin MJ; Geelhaar LA; Hamburger AW; Callery PS
    Cancer Res; 1988 Jul; 48(13):3613-6. PubMed ID: 3163938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different patterns of glycolipid antigens are expressed following differentiation of TERA-2 human embryonal carcinoma cells induced by retinoic acid, hexamethylene bisacetamide (HMBA) or bromodeoxyuridine (BUdR).
    Andrews PW; Nudelman E; Hakomori S; Fenderson BA
    Differentiation; 1990 Apr; 43(2):131-8. PubMed ID: 2373286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of transforming growth factor beta 1 in induction of colon carcinoma differentiation by hexamethylene bisacetamide.
    Schroy P; Rifkin J; Coffey RJ; Winawer S; Friedman E
    Cancer Res; 1990 Jan; 50(2):261-5. PubMed ID: 2295065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differentiation effect of hexamethylene bisacetamide (HMBA) on mucoepidermoid carcinoma in vivo].
    Jia B; Situ Z; Wu J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Mar; 31(2):85-7. PubMed ID: 9387538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemically induced bidirectional differentiation of embryonal carcinoma cells in vitro.
    Speers WC; Birdwell CR; Dixon FJ
    Am J Pathol; 1979 Dec; 97(3):563-84. PubMed ID: 507191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of AML serum on normal human myeloid differentiation and hexamethylene bisacetamide-induced granulocytic differentiation of the human HL-60 promyelocytic leukaemic cell line.
    Hassan HT; Rees JK
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(1):151-9. PubMed ID: 1695170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tropomyosin synthesis accompanies formation of actin filaments in embryonal carcinoma cells induced to differentiate by hexamethylene bisacetamide.
    Paulin D; Perreau J; Jakob H; Jacob F; Yaniv M
    Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1891-5. PubMed ID: 377290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of hexamethylene bisacetamide on related genes expression of apoptosis and cell proliferating in human mucoepidermoid carcinoma cell line MEC-1].
    Wang L; Wang J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2002 Mar; 37(2):120-2. PubMed ID: 12475424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60.
    Breitman TR; He RY
    Cancer Res; 1990 Oct; 50(19):6268-73. PubMed ID: 2400989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.
    Marks PA; Rifkind RA
    Int J Cell Cloning; 1988 Jul; 6(4):230-40. PubMed ID: 3047266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Human mucoepidermoid carcinoma MEC-1 cells induced differentiation by HMBA].
    Chen Y; SiTu Z; Wu J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Jan; 31(1):28-30. PubMed ID: 9275610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivation and characterization of retinoid-resistant human embryonal carcinoma cells.
    Moasser MM; Khoo KS; Maerz WJ; Zelenetz A; Dmitrovsky E
    Differentiation; 1996 Jul; 60(4):251-7. PubMed ID: 8765055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of class I major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition, or resistance to viral infection.
    Andrews PW; Trinchieri G; Perussia B; Baglioni C
    Cancer Res; 1987 Feb; 47(3):740-6. PubMed ID: 3026615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An active, aldehydic metabolite of the cell-differentiating agent hexamethylene bisacetamide.
    Subramanyam B; Callery PS; Egorin MJ; Snyder SW; Conley BA
    Drug Metab Dispos; 1989; 17(4):398-401. PubMed ID: 2571479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activin A inhibits growth and hexamethylene bisacetamide-induced differentiation in human retinoblastoma Y-79 cells.
    Zhang Z; Batres Y; Ying SY
    Anticancer Res; 1996; 16(1):269-72. PubMed ID: 8615619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.